Form 4: Core Labs Exec Vests Performance Shares After Strong ROIC

Core Laboratories Inc. SVP Mark Tattoli vested 24,952 performance shares after the company exceeded its return on invested capital target.

Summary

• Mark Tattoli, SVP, General Counsel & Secretary of Core Laboratories Inc., acquired 24,952 shares of common stock on December 31, 2025, through the vesting of performance shares.
• These shares were originally awarded as restricted performance shares in February 2023.
• The vesting occurred because Core Laboratories Inc. achieved the 68th percentile in return on invested capital among its Bloomberg Peer Group by December 31, 2025.
• The performance criteria were satisfied at 116.5% of the target award level.
• Concurrently, 14,310 shares were disposed of at $16.03, likely for tax withholding purposes related to the vesting.
• Following these transactions, Tattoli directly owns 27,360.621 shares, and indirectly owns 20 shares in a custodial account and 1,694.842 shares in a 401(k) Plan.

Sentiment

Score: 8

Explanation: The vesting of performance shares at 116.5% of target, driven by the company's 68th percentile ROIC performance, indicates strong operational execution and positive alignment of executive incentives with shareholder value.

Positives

• Core Laboratories Inc. achieved strong performance, finishing in the 68th percentile of return on invested capital among its Bloomberg Peer Group.
• Performance criteria for the restricted shares were satisfied at 116.5% of the target award level, indicating overachievement.
• The vesting of performance shares aligns management incentives with shareholder value creation.

Negatives

• Disposition of 14,310 shares, likely for tax purposes, represents a reduction in direct holdings, though this is a common practice with equity awards.

Industry Context

This filing indicates that Core Laboratories Inc. has performed well relative to its industry peers in terms of return on invested capital, suggesting strong operational efficiency or market positioning within the energy services sector.

Comparison to Industry Standards

• Core Laboratories Inc. achieved the 68th percentile in return on invested capital among its Bloomberg Peer Group, indicating above-average performance compared to industry competitors.

Stakeholder Impact

• Shareholders: Positive, as executive compensation is tied to strong company performance (ROIC), aligning interests. The overachievement of targets suggests good management.
• Employees: Positive, as it demonstrates the company's ability to meet and exceed performance targets, potentially fostering a positive work environment and future opportunities.

Key Dates

Recommendation

The vesting of performance shares at 116.5% of the target award level, driven by Core Laboratories Inc. achieving the 68th percentile in return on invested capital among its Bloomberg Peer Group, signals robust operational performance and effective management. This strong execution, leading to overachievement of internal targets, suggests a positive outlook for the company's fundamentals and aligns executive incentives with shareholder value creation, making it an attractive investment.

Keywords

Core Laboratories, CLB, Form 4, Insider Transaction, Performance Shares, Equity Vesting, Executive Compensation, Return on Invested Capital, Mark Tattoli